The S&P 500 snapped a five-month winning streak in August as a rise in U.S. Treasury yields weighed on shares of heavyweight growth stocks such as Apple and Microsoft , whose future cash flows are discounted more with a rise in rates.
J&J unveiled the first outlook for its standalone drugs and medical device businesses late last month after completing the spinoff of its consumer health company Kenvue.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: